University of Tennessee Cancer Institute
3 clinical trials · Sponsor
◉ Watch University of Tennessee Cancer Institute
| Record | Firm | Date |
|---|---|---|
| Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT01015664) | University of Tennessee Cancer Institute | 2010-02-01 |
| Temsirolimus as Second-line Therapy in HCC (NCT01567930) | University of Tennessee Cancer Institute | 2010-02-01 |
| Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery. (NCT00777673) | University of Tennessee Cancer Institute | 2008-10-01 |
Track University of Tennessee Cancer Institute automatically
Every clearance here is in the API, with alerts when new ones post.